Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,960,659
-
Share change
-
-7,009,773
-
Total reported value
-
$14,546,356
-
Price per share
-
$1.46
-
Number of holders
-
59
-
Value change
-
-$24,921,403
-
Number of buys
-
32
-
Number of sells
-
21
Institutional Holders of GENOCEA BIOSCIENCES INC - COM (GNCA) as of Q3 2017
As of 30 Sep 2017,
GENOCEA BIOSCIENCES INC - COM (GNCA) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,960,659 shares.
The largest 10 holders included
Polaris Venture Management Co. V, L.L.C., BlackRock Inc., VANGUARD GROUP INC, FMR LLC, NORTHPOINTE CAPITAL LLC, AXA, SPHERA FUNDS MANAGEMENT LTD., STATE STREET CORP, NORTHERN TRUST CORP, and AlphaMark Advisors, LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.